Browsing by Author "Prieto, C"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Human intraplatelet 5-hydroxytryptamine is correlated with mean platelet survival time
    (PERGAMON-ELSEVIER SCIENCE LTD, 1996) Aranda, E; Pereira, J; Ajenjo, C; Prieto, C; Sepulveda, S; Mezzano, D
  • Thumbnail Image
    Item
    Platelet membrane glycoprotein polymorphisms do not influence the clinical expressivity of von Willebrand disease type I
    (SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN, 2003) Pereira, J; Quiroga, T; Pereira, ME; Morales, M; Goycoolea, M; Hidalgo, P; Prieto, C; Mezzano, D
    Von Willebrand disease (VWD) is characterized by a significant variation in bleeding symptoms among patients with similar laboratory profiles and equivalent plasma levels of von Willebrand factor (VWF) activities. Considering the recent suggestion that platelet membrane glycoprotein polymorphisms (PltGPs) may play a role as modulators of thromboembolic or haemorrhagic diseases, we investigated the role of different PltGPs and GPVI content in the clinical expression of patients with VWD type 1. The diagnosis of VWD (n = 76) was based on laboratory findings (VWF:Ag, VWF:RCo, VWF:CB, FVIII:C, and multimer analysis), family and personal history of bleeding. All patients were interviewed using a standardized questionnaire, and classified into two categories: bleeders (unequivocal bleeding tendency, n = 53) and non bleeders (absence of bleeding symptoms, n = 23). PltGPs, HPA-1, 2 and 5 and C807T of GPla were determined by fluorophore-labelled hybridization probes on a LightCycler(TM). GPVI content was measured by western blotting.